Home
Contact
✕
Targeted therapy
Home
Targeted therapy
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
All
Acute lymphoblastic leukemia
Adolescents and young adults
Advocacy
Anal cancer
Antioxidants
Bladder cancer
Blood cancers
Breast cancer
Cancer care delivery
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
Communication
COVID-19
De-escalation
Esophagus cancer
GI cancer
Green tea
Head and neck cancer
Health equity
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Language
Late Effects
Leukemia
Liver cancer
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Mesothelioma
Minimal residual disease
MRI
Multiple myeloma
Myeloma
NCI-MATCH
Neuropathy
Nose and sinus cancer
Older adults
Pancreatic cancer
Pancreatic cysts
Patient-reported outcomes
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Squamous cell carcinoma
Surveillance
Survivorship
Symptom management
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Diane Dragaud
ecogacrinnews2
Katie Heller
January 5, 2023
January 5, 2023
Categories
Ongoing Trials
Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023
January 5, 2023
Categories
Ongoing Trials
Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer
This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021
December 15, 2021
Categories
New Trials
Now Enrolling: The OPTIMUM clinical trial is studying an additional treatment for patients with multiple myeloma
This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant
December 15, 2021
December 15, 2021
Categories
Ongoing Trials
Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread
This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
1
2
3
Next page